🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05296889
Recruiting Observational

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

NCT05296889 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2021-07-21
Last updated
2026-08-03

Condition(s) studied

Spine FractureDegenerative Disc DiseaseSpinal InstabilitySpinal TumorDegenerative Myelopathy

Investigational drug(s) / intervention(s)

posterior stabilization for the cervical spine

posterior stabilization for the cervical spine: The Ennovate® Cervical Spinal System is a posterior stabilization for the cervical and upper-thoracic spine. The implants are used for the posterior monosegmental and multisegmental stabilization of the occipitocervical junction and of the cervical and upper thoracic spine.

Study summary

Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient is minimum 18 years old * Informed Consent in the documentation of clinical and radiological results * Patient has indication according to Instructions for Use (IFU) * Patient is not pregnant Exclusion Criteria: * Patient's clear unability or unwillingness to participate in follow-up examinations

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Schön Klinik Hamburg Eilbek Hamburg Free and Hanseatic City of Hamburg Active Not Recruiting
Krankenhaus Ludmillenstift Meppen Meppen Lower Saxony Not Yet Recruiting
Städtisches Klinikum Dresden Dresden Saxony Not Yet Recruiting
Berufsgenossenschaft Klinikum Bergmannstrost Halle / Saale Halle Saxony-Anhalt Recruiting

More Aesculap AG trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05296889 on ClinicalTrials.gov ↗ ← All trials in Germany